Welcome to the New Mexico Chapter of the American College of Cardiology
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Please join your cardiology colleagues at the ACC Rockies Chapter Meeting in Park City, Utah for updates on ACC affairs, the potential new CV Board, and clinical topics such as Genetic and Sports EP, plus a discussion on the growing role of obesity medications in heart failure, and the first-ever Cardiology State-of-the-State report. There will be many opportunities for networking, as well!.
For more information and to register, please visit: 
Latest in Cardiology from ACC.org
- Driving Community-Based Change at the Heart of New Fuster Prevention ForumACC's newly launched Fuster Prevention Forum, designed to honor the contributions of Valentin Fuster, MD, PhD, MACC, and his lifelong commitment to establishing a culture of prevention, will teach clinicians effective ways to educate children, parents and educators in their communities on nutrition, physical activity and emotional well-being.
- 2025 ACC/AHA Sports Participation Guidelines For Athletes With CV Abnormalities: A Paradigm Shift Toward Shared Decision-MakingThe 2025 American Heart Association/American College of Cardiology (AHA/ACC) scientific statement on Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities provides evolving insights and clinical guidance in the field of sports cardiology.
- Eagle’s Eye View: A Change in Food Labeling to Improve CV HealthIn this week’s View, Dr. Eagle looks at the use of PREVENT equations to assess cardiovascular (CV) disease risk and the CREST-2 randomized trials that examined stenting versus endarterectomy for asymptomatic carotid disease.
- ACCEL Lite: ACCEL Lite: Top Takeaways from 2025: Interventional Cardiology with Deepak Bhatt, MD, MPH, MBA, FACCIn this interview, Deepak Bhatt, MD, MPH, FACC and Alison L. Bailey, MD FACC, discuss the Top Interventional Cardiology Takeaways from 2025 including DanGer Shock trial, revascularization in STEMI, aspirin withdrawal after PCI, and more.
- ACC Issues Guidance For Managing CV Risks Associated With Cancer TreatmentsWith modern cancer therapeutics changing the landscape of cancer treatment, the need to address cardiovascular treatment-related complications is increasingly important. A new ACC Concise Clinical Guidance report on the Diagnosis and Management of Cardiovascular Adverse Effects of Targeted Oncology Therapies addresses this need by focusing on three classes of anticancer therapies: Bruton’s tyrosine kinase (BTK) […]